2022 - 2022

FUROSCIX®

FUROSCIX Approval and Financing

  • Resubmission of FUROSCIX® (furosemide injection) New Drug Application
  • Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure
  • FDA Approval of FUROSCIX® (furosemide injection)
  • $100 Million Debt Financing Agreement with Oaktree

scPharmaceuticals is now part of MannKind. We’re excited about this new chapter and what it means for our team, partners, and patients.

Visit MannKind

scPharmaceuticals is now part of MannKind. We’re excited about this new chapter and what it means for our team, partners, and patients.

Visit MannKind

scPharmaceuticals is now part of MannKind. We’re excited about this new chapter and what it means for our team, partners, and patients.

Visit MannKind